Anebulo Other Non Cash Items vs Net Income Analysis
| ANEB Stock | USD 1.46 0.17 10.43% |
Anebulo Pharmaceuticals financial indicator trend analysis is way more than just evaluating Anebulo Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anebulo Pharmaceuticals is a good investment. Please check the relationship between Anebulo Pharmaceuticals Other Non Cash Items and its Net Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.
Other Non Cash Items vs Net Income
Other Non Cash Items vs Net Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anebulo Pharmaceuticals Other Non Cash Items account and Net Income. At this time, the significance of the direction appears to have pay attention.
The correlation between Anebulo Pharmaceuticals' Other Non Cash Items and Net Income is -0.85. Overlapping area represents the amount of variation of Other Non Cash Items that can explain the historical movement of Net Income in the same time period over historical financial statements of Anebulo Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Anebulo Pharmaceuticals' Other Non Cash Items and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Non Cash Items of Anebulo Pharmaceuticals are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Other Non Cash Items i.e., Anebulo Pharmaceuticals' Other Non Cash Items and Net Income go up and down completely randomly.
Correlation Coefficient | -0.85 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Other Non Cash Items
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Anebulo Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Anebulo Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most indicators from Anebulo Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anebulo Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.The current year's Enterprise Value is expected to grow to about 115.6 M, whereas Selling General Administrative is forecasted to decline to about 3.6 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Depreciation And Amortization | 11.8K | 258.3K | 232.5K | 220.8K | Interest Income | 147.6K | 249.0K | 286.4K | 300.7K |
Anebulo Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Anebulo Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anebulo Pharmaceuticals fundamental ratios Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 21.7M | 15.6M | 11.7M | 4.1M | 3.7M | 3.5M | |
| Other Current Liab | 131.6K | 131.7K | 534.3K | 104.2K | 119.8K | 203.3K | |
| Total Current Liabilities | 241.6K | 512.5K | 534.5K | 260.6K | 299.7K | 390.1K | |
| Total Stockholder Equity | 21.4M | 15.1M | 10.6M | 3.8M | 3.4M | 3.3M | |
| Net Debt | (20.0M) | (14.5M) | (11.2M) | (3.1M) | (3.6M) | (3.7M) | |
| Retained Earnings | (38.6M) | (45.5M) | (57.2M) | (65.4M) | (58.9M) | (61.8M) | |
| Accounts Payable | 110.0K | 380.8K | 534.5K | 156.4K | 179.9K | 260.0K | |
| Cash | 20.0M | 14.5M | 11.2M | 3.1M | 2.8M | 2.6M | |
| Cash And Short Term Investments | 20.0M | 14.5M | 11.2M | 3.1M | 2.8M | 2.6M | |
| Liabilities And Stockholders Equity | 21.7M | 15.6M | 11.7M | 4.1M | 3.7M | 3.5M | |
| Non Current Liabilities Total | 131.6K | 380.8K | 534.3K | 104.2K | 93.7K | 89.1K | |
| Other Current Assets | 1.7M | 1.0M | 422.7K | 413.8K | 372.4K | 565.7K | |
| Other Stockholder Equity | 38.4M | 60.5M | 67.8M | 69.2M | 79.6M | 51.9M | |
| Total Liab | 241.6K | 512.5K | 1.1M | 260.6K | 234.5K | 222.8K | |
| Total Current Assets | 20.0M | 14.5M | 11.2M | 3.5M | 3.2M | 3.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anebulo Pharmaceuticals. If investors know Anebulo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anebulo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Anebulo Pharmaceuticals is measured differently than its book value, which is the value of Anebulo that is recorded on the company's balance sheet. Investors also form their own opinion of Anebulo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Anebulo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anebulo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Anebulo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anebulo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anebulo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anebulo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.